![Frank Verwiel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Verwiel
Chairman at
INTELLIA THERAPEUTICS, INC.
Net worth: 649 414 $ as of 2026-05-30
Profile
Frank A. G. M. Verwiel is a Dutch businessperson who has been at the helm of 6 different companies. He holds the position of Chairman of ObsEva SA, Chairman for Intellia Therapeutics, Inc. and President of Aptalis Pharma US, Inc. He is also on the board of Bavarian Nordic An and Bavarian Nordic GmbH. In his past career Frank A. G. M. Verwiel occupied the position of VP-Hypertension & Worldwide Human Health Marketing at Merck & Co., Inc., President, Chief Executive Officer & Director at Aptalis Pharma, Inc., President & Chief Executive Officer of Aptalis Pharma SAS, President, Chief Executive Officer & Director at Aptalis Holdings, Inc. and Director & Director-Health Section Governing Board at Biotechnology Innovation Organization. Frank A. G. M. Verwiel received an MBA from INSEAD and a doctorate from Erasmus University Rotterdam.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-08 | 35,148 ( 0.03% ) | 494 532 $ | 2026-05-30 | |
BAVARIAN NORDIC A/S 0.01% | 2025-12-30 | 5,293 ( 0.01% ) | 154 882 $ | 2026-05-30 |
Frank Verwiel active positions
| Companies | Position | Start |
|---|---|---|
| BAVARIAN NORDIC A/S | Director/Board Member | 2016-04-19 |
| INTELLIA THERAPEUTICS, INC. | Chairman | 2020-01-31 |
Aptalis Pharma US, Inc.
 Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Markets pharmaceutical products for the treatment of gastrointestinal diseases and disorders | President | - |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer and infectious diseases | Director/Board Member | 2015-12-31 |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Director/Board Member | 2019-07-31 |
Former positions of Frank Verwiel
| Companies | Position | End |
|---|---|---|
| OBSEVA SA | Chairman | 2022-05-17 |
| ACHILLION PHARMACEUTICALS, INC. | Director/Board Member | 2020-01-27 |
| AVEXIS INC | Director/Board Member | 2018-05-31 |
| INTERMUNE INC | Director/Board Member | 2014-08-31 |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Frank Verwiel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology | Health Technology |
Aptalis Pharma US, Inc.
Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Markets pharmaceutical products for the treatment of gastrointestinal diseases and disorders | Health Technology |
Bavarian Nordic A/S
 Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TA SASU
 TA SASU Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on gastrointestinal diseases and cystic fibrosis | Health Technology |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer and infectious diseases | Health Technology |
Aptalis Holdings, Inc.
 Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operating as a holding company that develops, manufactures, licenses, markets and distributes therapies | Health Technology |
ObsEva SA
 ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
- Stock Market
- Insiders
- Frank Verwiel
